You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 6,451,552


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,451,552
Title: Method for the selective degradation of milk protein in the presence of other milk proteins
Abstract:A method is presented for producing a casein/caseinate hydrolysate stripped of immunogenic proteins. The method comprises treating an aqueous solution, such as milk, comprising casein/caseinate and immunogenic protein other than casein with a protease that selectively hydrolyzes casein. After the casein/caseinate has been hydrolyzed, the casein/caseinate hydrolyzate is separated by membrane ultrafiltration from unhydrolyzed immunogenic protein and recovered. The resulting hydrolyzate is essentially free of antigenic components of the ABBOS peptide and bovine serum albumin. The casein selective protease is selected from cell wall proteinase of Lactococcus lactis subsp. Cremoris Wg2, a Clostridium histolyticum collagenase and a Bacillus polymyxa dispase.
Inventor(s): Van Beresteijn; Emmerentia Catharine Henriette (Ede, NL), Alting; Aart Cornelis (Ede, NL)
Assignee: Nederlands Instituut voor Zuivelonderzoek (NL)
Application Number:09/341,785
Patent Claims:1. A method for producing a casein/caseinate hydrolysate that is stripped of immunogenic protein other than casein/caseinate, the method comprising the steps of: a) providing an aqueous solution containing essentially dissolved casein/caseinate and an essentially dissolved immunogenic protein other than casein/caseinate; b) adding to the aqueous solution a casein-specific proteolytic enzyme; c) incubating the aqueous solution and the casein-specific proteolytic enzyme under conditions such that the casein/caseinate is hydrolysed while the immunogenic protein other than casein/caseinate remains essentially intact; d) separating the hydrolysed casein/caseinate and the essentially intact immunogenic protein other than casein/caseinate; and e) recovering the hydrolyzed casein/caseinate stripped of immunogenic protein.

2. The method of claim 1, wherein the immunogenic protein other than casein/caseinate is a whey protein.

3. The method of claim 2, wherein the whey protein is bovine serum albumin.

4. The method of claim 3, wherein essentially no detectable antigenic components of the ABBOS peptide are present in the casein/caseinate hydrolysate.

5. The method of claim 4, wherein essentially no detectable antigenic components of bovine serum albumin are present in the casein/caseinate hydrolysate.

6. The method of claim 1, wherein the aqueous solution is selected from the group consisting of milk, a fraction of milk, and an aqueous solution of milk proteins.

7. The method of claim 1 wherein the casein-specific proteolytic enzyme is selected from the group consisting of a Lactococcus cell wall proteinase, a collagenase and a dispase.

8. The method of claim 1, wherein the casein-specific enzyme is selected from the group consisting of a cell wall proteinase of Lactococcus lactis subsp. cremoris strain Wg2, a Clostridium histolyticum collagenase and a Bacillus polymyxa dispase.

9. The method of claim 1, wherein the separation in step (d) uses a separation method based on a characteristic selected from the group consisting of molecular mass and molecular size.

10. The method of claim 9, wherein the separation method is ultrafiltration.

11. The method of claim 10, wherein the ultrafiltration uses a molecular cut-off value in the range of 10-30 kDa.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.